Atopic Dermatitis

>

On the HCPLive Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Latest News

Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University School of Medicine
Weekly Cendakimab 720 mg Linked to Reduced EASI Scores in Atopic Dermatitis

July 17th 2024

A phase 2 trial showed cendakimab, an IL-13 inhibitor, reduced Eczema Area and Severity Index scores in moderate to severe atopic dermatitis patients.

Roflumilast Cream Receives FDA Approval for Atopic Dermatitis
Roflumilast Cream Receives FDA Approval for Atopic Dermatitis

July 9th 2024

Dupilumab for Atopic Dermatitis Led to Improvements in Comorbid Asthma, Other Benefits
Dupilumab for Atopic Dermatitis Led to Improvements in Comorbid Asthma, Other Benefits

July 9th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
Arcutis Offers Update on Application for Roflumilast Cream 0.15% with FDA

July 9th 2024

Updates to Guidelines Announced for Management of Atopic Dermatitis
Updates to Guidelines Announced for Management of Atopic Dermatitis

July 8th 2024

Video Series
Video Interviews
Podcasts
Advances in Pediatric Eczema Highlight 2022

More News

© 2024 MJH Life Sciences

All rights reserved.